Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 64 | 2022 | 20827 | 2.620 |
Why?
|
Mastectomy, Segmental | 18 | 2021 | 956 | 2.020 |
Why?
|
Mastectomy | 19 | 2022 | 1793 | 2.020 |
Why?
|
Mammaplasty | 6 | 2021 | 1204 | 1.280 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 9 | 2022 | 948 | 1.180 |
Why?
|
Carcinoma, Ductal, Breast | 11 | 2017 | 1100 | 0.900 |
Why?
|
Carcinoma, Lobular | 7 | 2017 | 484 | 0.760 |
Why?
|
Neoadjuvant Therapy | 7 | 2019 | 2727 | 0.660 |
Why?
|
Receptor, erbB-2 | 7 | 2018 | 2418 | 0.640 |
Why?
|
Staff Development | 1 | 2020 | 223 | 0.630 |
Why?
|
Chemotherapy, Adjuvant | 8 | 2019 | 3480 | 0.610 |
Why?
|
Preoperative Care | 5 | 2016 | 2251 | 0.580 |
Why?
|
Salaries and Fringe Benefits | 1 | 2019 | 263 | 0.580 |
Why?
|
Sentinel Lymph Node Biopsy | 3 | 2018 | 710 | 0.560 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2016 | 604 | 0.540 |
Why?
|
Receptors, Progesterone | 4 | 2016 | 1098 | 0.470 |
Why?
|
SEER Program | 10 | 2019 | 1507 | 0.460 |
Why?
|
Receptors, Estrogen | 8 | 2018 | 2190 | 0.450 |
Why?
|
Breast | 4 | 2018 | 1970 | 0.430 |
Why?
|
Neoplasm Staging | 17 | 2020 | 11036 | 0.410 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2012 | 104 | 0.400 |
Why?
|
Income | 1 | 2019 | 1913 | 0.370 |
Why?
|
Magnetic Resonance Imaging | 13 | 2022 | 35409 | 0.370 |
Why?
|
Socioeconomic Factors | 5 | 2019 | 7784 | 0.350 |
Why?
|
Leiomyosarcoma | 1 | 2012 | 477 | 0.320 |
Why?
|
Aged | 50 | 2022 | 163178 | 0.310 |
Why?
|
Female | 70 | 2022 | 380020 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2019 | 9239 | 0.310 |
Why?
|
Medicare | 8 | 2022 | 6565 | 0.280 |
Why?
|
Umbilicus | 1 | 2005 | 41 | 0.260 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2007 | 204 | 0.260 |
Why?
|
Physicians | 2 | 2022 | 4569 | 0.250 |
Why?
|
Intestinal Fistula | 1 | 2005 | 140 | 0.250 |
Why?
|
Early Detection of Cancer | 3 | 2019 | 3089 | 0.250 |
Why?
|
Appendix | 1 | 2005 | 110 | 0.250 |
Why?
|
Aged, 80 and over | 25 | 2019 | 57744 | 0.240 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2021 | 1770 | 0.240 |
Why?
|
Women's Health | 1 | 2014 | 2033 | 0.240 |
Why?
|
Lymph Node Excision | 5 | 2021 | 1262 | 0.240 |
Why?
|
Neoplasm Invasiveness | 7 | 2016 | 3617 | 0.230 |
Why?
|
Breast Neoplasms, Male | 2 | 2016 | 210 | 0.230 |
Why?
|
Humans | 75 | 2022 | 743811 | 0.230 |
Why?
|
United States | 28 | 2022 | 69859 | 0.220 |
Why?
|
Lymphatic Metastasis | 5 | 2017 | 2924 | 0.220 |
Why?
|
Insulin Resistance | 3 | 2022 | 3863 | 0.220 |
Why?
|
Middle Aged | 40 | 2020 | 213241 | 0.210 |
Why?
|
Cimicifuga | 1 | 2022 | 5 | 0.210 |
Why?
|
Mass Screening | 3 | 2016 | 5251 | 0.210 |
Why?
|
Prognosis | 12 | 2022 | 29052 | 0.210 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5319 | 0.200 |
Why?
|
Lymph Nodes | 4 | 2018 | 3476 | 0.200 |
Why?
|
Medical Order Entry Systems | 1 | 2007 | 545 | 0.190 |
Why?
|
Decision Making | 4 | 2019 | 3887 | 0.190 |
Why?
|
Databases, Factual | 7 | 2017 | 7729 | 0.190 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39001 | 0.180 |
Why?
|
Appendicitis | 1 | 2005 | 645 | 0.170 |
Why?
|
Workload | 1 | 2004 | 849 | 0.160 |
Why?
|
Hemangiosarcoma | 1 | 2021 | 239 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 11524 | 0.160 |
Why?
|
Seroma | 1 | 2018 | 71 | 0.160 |
Why?
|
Genetic Testing | 3 | 2020 | 3439 | 0.150 |
Why?
|
Genes, BRCA2 | 1 | 2020 | 618 | 0.150 |
Why?
|
Paget's Disease, Mammary | 1 | 2016 | 19 | 0.140 |
Why?
|
Genetic Counseling | 1 | 2020 | 600 | 0.140 |
Why?
|
Peer Group | 2 | 2018 | 635 | 0.140 |
Why?
|
Ki-67 Antigen | 2 | 2022 | 644 | 0.140 |
Why?
|
Mammography | 4 | 2016 | 2475 | 0.140 |
Why?
|
Refusal to Treat | 1 | 2016 | 45 | 0.140 |
Why?
|
Histiocytosis | 1 | 2016 | 40 | 0.140 |
Why?
|
Ultrasonography, Mammary | 2 | 2016 | 250 | 0.130 |
Why?
|
Retrospective Studies | 17 | 2021 | 77410 | 0.130 |
Why?
|
Adult | 29 | 2019 | 213889 | 0.130 |
Why?
|
Population Groups | 1 | 2016 | 209 | 0.130 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2016 | 143 | 0.120 |
Why?
|
Carcinoma | 2 | 2016 | 2375 | 0.120 |
Why?
|
Taxoids | 1 | 2018 | 666 | 0.120 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1639 | 0.120 |
Why?
|
General Surgery | 1 | 2004 | 1636 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2020 | 3155 | 0.110 |
Why?
|
Insurance Coverage | 2 | 2015 | 1900 | 0.110 |
Why?
|
Breast Diseases | 1 | 2016 | 443 | 0.110 |
Why?
|
Medical Record Linkage | 1 | 2014 | 284 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13691 | 0.110 |
Why?
|
Employment | 1 | 2019 | 1132 | 0.110 |
Why?
|
Fee-for-Service Plans | 2 | 2014 | 694 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12243 | 0.100 |
Why?
|
Surgical Flaps | 1 | 2020 | 1629 | 0.100 |
Why?
|
Cohort Studies | 8 | 2022 | 40545 | 0.100 |
Why?
|
Tumor Burden | 4 | 2022 | 1917 | 0.100 |
Why?
|
Pediatrics | 1 | 2007 | 3474 | 0.100 |
Why?
|
Intraoperative Care | 1 | 2015 | 767 | 0.100 |
Why?
|
Lymphedema | 1 | 2018 | 534 | 0.100 |
Why?
|
Carcinoma in Situ | 2 | 2015 | 805 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1523 | 0.100 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1077 | 0.090 |
Why?
|
Leadership | 1 | 2020 | 1357 | 0.090 |
Why?
|
Hospital Costs | 1 | 2017 | 985 | 0.090 |
Why?
|
Surgery, Plastic | 1 | 2017 | 624 | 0.090 |
Why?
|
Health Surveys | 3 | 2019 | 4036 | 0.090 |
Why?
|
Patient Satisfaction | 2 | 2019 | 3391 | 0.090 |
Why?
|
Risk Assessment | 3 | 2019 | 23327 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2015 | 915 | 0.090 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6237 | 0.080 |
Why?
|
Insurance, Health | 2 | 2015 | 2492 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1539 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2012 | 491 | 0.080 |
Why?
|
Gamma Rays | 1 | 2009 | 320 | 0.080 |
Why?
|
Logistic Models | 4 | 2016 | 13404 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1063 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 1971 | 0.080 |
Why?
|
Fatal Outcome | 1 | 2012 | 1851 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2020 | 63042 | 0.080 |
Why?
|
Pain, Postoperative | 1 | 2018 | 1642 | 0.080 |
Why?
|
Life Style | 1 | 2019 | 3833 | 0.080 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 1049 | 0.080 |
Why?
|
Survivors | 2 | 2015 | 2291 | 0.080 |
Why?
|
Health Behavior | 1 | 2019 | 2634 | 0.080 |
Why?
|
Societies, Medical | 1 | 2019 | 3740 | 0.070 |
Why?
|
Health Expenditures | 2 | 2017 | 2348 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3583 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3965 | 0.070 |
Why?
|
Perception | 1 | 2012 | 1198 | 0.070 |
Why?
|
Health Care Surveys | 2 | 2019 | 2453 | 0.070 |
Why?
|
Incidence | 4 | 2016 | 20948 | 0.070 |
Why?
|
Risk Factors | 4 | 2019 | 72252 | 0.070 |
Why?
|
Age Factors | 6 | 2019 | 18355 | 0.060 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 2034 | 0.060 |
Why?
|
Health Services Accessibility | 2 | 2017 | 5136 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5100 | 0.060 |
Why?
|
Brachytherapy | 1 | 2012 | 1247 | 0.060 |
Why?
|
Internship and Residency | 1 | 2004 | 5787 | 0.060 |
Why?
|
Cost of Illness | 1 | 2014 | 1859 | 0.060 |
Why?
|
Comorbidity | 2 | 2015 | 10380 | 0.060 |
Why?
|
Hospital Information Systems | 1 | 2007 | 395 | 0.060 |
Why?
|
Combined Modality Therapy | 4 | 2017 | 8637 | 0.060 |
Why?
|
Time Factors | 3 | 2019 | 40038 | 0.060 |
Why?
|
Private Sector | 1 | 2006 | 393 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5611 | 0.050 |
Why?
|
Appendectomy | 1 | 2005 | 401 | 0.050 |
Why?
|
Liver Neoplasms | 2 | 2012 | 4251 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1956 | 0.050 |
Why?
|
Axilla | 2 | 2016 | 597 | 0.050 |
Why?
|
Reoperation | 3 | 2017 | 4200 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4033 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 12718 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5388 | 0.050 |
Why?
|
Estrogen Antagonists | 1 | 2022 | 151 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2021 | 15281 | 0.050 |
Why?
|
Male | 11 | 2020 | 349776 | 0.050 |
Why?
|
Diet | 1 | 2019 | 7930 | 0.050 |
Why?
|
Biopsy | 1 | 2012 | 6750 | 0.050 |
Why?
|
Colectomy | 1 | 2005 | 680 | 0.050 |
Why?
|
Medication Errors | 1 | 2007 | 798 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2529 | 0.050 |
Why?
|
Registries | 1 | 2015 | 8090 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17439 | 0.040 |
Why?
|
Mental Health | 1 | 2013 | 3012 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6363 | 0.040 |
Why?
|
Hepatectomy | 1 | 2002 | 550 | 0.040 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 3839 | 0.040 |
Why?
|
Prospective Studies | 4 | 2017 | 53250 | 0.040 |
Why?
|
Epirubicin | 1 | 2018 | 80 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14714 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2020 | 273 | 0.040 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2019 | 145 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2020 | 390 | 0.040 |
Why?
|
Perioperative Period | 1 | 2018 | 256 | 0.040 |
Why?
|
Cryosurgery | 1 | 2002 | 453 | 0.040 |
Why?
|
Orthopedics | 1 | 2006 | 904 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20121 | 0.030 |
Why?
|
Connecticut | 1 | 2017 | 366 | 0.030 |
Why?
|
Histiocytosis, Sinus | 1 | 2016 | 47 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 550 | 0.030 |
Why?
|
Receptor, Insulin | 1 | 2020 | 846 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25032 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 4260 | 0.030 |
Why?
|
Friends | 1 | 2017 | 154 | 0.030 |
Why?
|
Body Weight | 1 | 2007 | 4670 | 0.030 |
Why?
|
Radiotherapy, Conformal | 1 | 2019 | 548 | 0.030 |
Why?
|
Medically Underserved Area | 1 | 2017 | 252 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 230 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.030 |
Why?
|
Life Expectancy | 1 | 2019 | 1184 | 0.030 |
Why?
|
Fluorouracil | 1 | 2018 | 1619 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2017 | 1586 | 0.030 |
Why?
|
Adolescent | 5 | 2016 | 85729 | 0.030 |
Why?
|
Medicaid | 1 | 2006 | 2736 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2013 | 719 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2019 | 1529 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2879 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2018 | 2241 | 0.030 |
Why?
|
Primary Prevention | 1 | 2019 | 1167 | 0.020 |
Why?
|
Paclitaxel | 1 | 2018 | 1705 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2005 | 12954 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2617 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 1624 | 0.020 |
Why?
|
Physical Examination | 1 | 2016 | 1235 | 0.020 |
Why?
|
Laparoscopy | 1 | 2002 | 2148 | 0.020 |
Why?
|
Radiotherapy | 1 | 2017 | 1533 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1841 | 0.020 |
Why?
|
Physician's Role | 1 | 2017 | 942 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1781 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2503 | 0.020 |
Why?
|
Information Dissemination | 1 | 2017 | 1099 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8316 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2459 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2012 | 13112 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2614 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2013 | 1680 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3503 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2017 | 2278 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2007 | 25609 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3530 | 0.020 |
Why?
|
Family | 1 | 2017 | 3144 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4031 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3229 | 0.020 |
Why?
|
Health Personnel | 1 | 2019 | 3217 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 21675 | 0.020 |
Why?
|
Communication | 1 | 2019 | 3748 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5078 | 0.020 |
Why?
|
Infant | 1 | 2007 | 35122 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11360 | 0.020 |
Why?
|
Health Policy | 1 | 2017 | 2662 | 0.020 |
Why?
|
Young Adult | 3 | 2016 | 56392 | 0.020 |
Why?
|
Calcinosis | 1 | 2013 | 1495 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 6457 | 0.020 |
Why?
|
Quality of Life | 2 | 2017 | 12788 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 40964 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 7010 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10251 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5986 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5714 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8430 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9440 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6539 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10394 | 0.010 |
Why?
|
Child | 2 | 2007 | 77637 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3921 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4210 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 9944 | 0.010 |
Why?
|
Survival Rate | 1 | 2013 | 12786 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9582 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13869 | 0.010 |
Why?
|
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_